Verona Pharma Enters into Debt Facility of Up to $400 Million with Oxford Finance and Hercules Capital
Strengthens financial flexibility to support the Company’s continued growth Verona Pharma plc, announces it and its wholly-owned subsidiary, Verona Pharma, Inc. (the “Company”), have entered into a debt financing facility (“debt facility”) providing the Company with access to up to $400 million from funds managed by Oxford Finance LLC (“Oxford”)......